Drug intelligence / Profile preview

Human (allogeneic) iPS cell derived-cardiomyocyte sheet

Development stage
Phase 1
Lead developer
Cuorips
Modality
iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies
Administration
Surgical Implantation, Epicardial
01

Overview

Human (allogeneic) iPS cell derived-cardiomyocyte sheet is a regenerative therapy developed for treating ischemic cardiomyopathy. This therapy involves transplanting sheets of cardiomyocytes (heart muscle cells) derived from allogeneic induced pluripotent stem cells (iPSCs). The cardiomyocyte sheets are applied to damaged heart tissue to improve cardiac function. These iPSC-derived cardiomyocytes beat spontaneously and produce cytokines that induce angiogenesis, potentially repairing myocardial tissue through both mechanical contraction and paracrine effects. The therapy is administered in combination with immunosuppressants to prevent rejection of the allogeneic cells.

Brand names
Cuorips
Other names
human induced pluripotent stem cell-derived cardiomyocytehiPSC-CM patchiPSC-CM patch

Beyond the preview

Go deeper on Human (allogeneic) iPS cell derived-cardiomyocyte sheet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human (allogeneic) iPS cell derived-cardiomyocyte sheet.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call